IRIS Accounts Production v25.3.0.601 09965369 Board of Directors Board of Directors 1.2.24 31.1.25 31.1.25 false true false false false true false Ordinary share 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 09965369 2024-01-31 09965369 2025-01-31 09965369 2024-02-01 2025-01-31 09965369 2023-01-31 09965369 2023-02-01 2024-01-31 09965369 2024-01-31 09965369 ns15:EnglandWales 2024-02-01 2025-01-31 09965369 ns14:PoundSterling 2024-02-01 2025-01-31 09965369 ns10:Director1 2024-02-01 2025-01-31 09965369 ns10:Director2 2024-02-01 2025-01-31 09965369 ns10:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 09965369 ns10:SmallEntities 2024-02-01 2025-01-31 09965369 ns10:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 09965369 ns10:SmallCompaniesRegimeForDirectorsReport 2024-02-01 2025-01-31 09965369 ns10:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 09965369 ns10:FullAccounts 2024-02-01 2025-01-31 09965369 1 2024-02-01 2025-01-31 09965369 ns10:OrdinaryShareClass1 2024-02-01 2025-01-31 09965369 ns10:RegisteredOffice 2024-02-01 2025-01-31 09965369 ns5:CurrentFinancialInstruments 2025-01-31 09965369 ns5:CurrentFinancialInstruments 2024-01-31 09965369 ns5:Non-currentFinancialInstruments 2025-01-31 09965369 ns5:Non-currentFinancialInstruments 2024-01-31 09965369 ns5:ShareCapital 2025-01-31 09965369 ns5:ShareCapital 2024-01-31 09965369 ns5:RetainedEarningsAccumulatedLosses 2025-01-31 09965369 ns5:RetainedEarningsAccumulatedLosses 2024-01-31 09965369 ns5:NetGoodwill 2024-01-31 09965369 ns5:NetGoodwill 2024-02-01 2025-01-31 09965369 ns5:NetGoodwill 2025-01-31 09965369 ns5:NetGoodwill 2024-01-31 09965369 ns5:PlantMachinery 2024-01-31 09965369 ns5:FurnitureFittings 2024-01-31 09965369 ns5:ComputerEquipment 2024-01-31 09965369 ns5:PlantMachinery 2024-02-01 2025-01-31 09965369 ns5:FurnitureFittings 2024-02-01 2025-01-31 09965369 ns5:ComputerEquipment 2024-02-01 2025-01-31 09965369 ns5:PlantMachinery 2025-01-31 09965369 ns5:FurnitureFittings 2025-01-31 09965369 ns5:ComputerEquipment 2025-01-31 09965369 ns5:PlantMachinery 2024-01-31 09965369 ns5:FurnitureFittings 2024-01-31 09965369 ns5:ComputerEquipment 2024-01-31 09965369 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-01-31 09965369 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-01-31 09965369 ns10:OrdinaryShareClass1 2025-01-31

REGISTERED NUMBER: 09965369 (England and Wales)

Imeds4u Ltd

Unaudited Financial Statements

for the Year Ended 31 January 2025

| Imeds4u Ltd (Registered number: 09965369) |

Contents of the Financial Statements

for the Year Ended 31 January 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

| Imeds4u Ltd |

Company Information

for the Year Ended 31 January 2025

| DIRECTORS: | Mr M J Jennings

| Mrs F B Khanum

| REGISTERED OFFICE: | Suite 2,3 Parkway House

| Palatine Road

| Manchester

| M22 4DB

| REGISTERED NUMBER: | 09965369 (England and Wales)

| Imeds4u Ltd (Registered number: 09965369) |

Balance Sheet

31 January 2025

| 2025 |  | 2024

| Notes | £ | £ |

FIXED ASSETS

Intangible assets | 5 | 4,905 |  | 6,540 |  |

Tangible assets | 6 | - |  | 13,406 |  |

4,905 |  | 19,946 |  |

CURRENT ASSETS

Stocks | 35,000 |  | 35,000 |  |

Debtors | 7 | 53,848 |  | 32,556 |  |

Cash at bank | 20,125 |  | 18,131 |  |

108,973 |  | 85,687 |  |

CREDITORS

Amounts falling due within one year | 8 | (101,828 | ) | (81,257 | ) |

NET CURRENT ASSETS | 7,145 |  | 4,430 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 12,050 |  | 24,376 |  |

CREDITORS

Amounts falling due after more than one year | 9 | (11,227 | ) | (19,197 | ) |

PROVISIONS FOR LIABILITIES | - |  | (3,351 | ) |

NET ASSETS | 823 |  | 1,828 |  |

CAPITAL AND RESERVES

Called up share capital | 10 | 100 |  | 100 |  |

Retained earnings | 723 |  | 1,728 |  |

SHAREHOLDERS' FUNDS | 823 |  | 1,828 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

| Imeds4u Ltd (Registered number: 09965369) |

Balance Sheet - continued

31 January 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 October 2025 and were signed on its behalf by:

Mr M J Jennings - Director

Mrs F B Khanum - Director

| Imeds4u Ltd (Registered number: 09965369) |

Notes to the Financial Statements

for the Year Ended 31 January 2025

1. | GENERAL INFORMATION

| The company is a private company limited by share capital, incorporated in United Kingdom.

| The registered office is

| Suite 2

| 3 Parkway House

| Palatine Road

| Manchester

| M22 4DB.

2. | STATEMENT OF COMPLIANCE

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

3. | ACCOUNTING POLICIES

| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES

| The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

| BASIS OF PREPARATION

| These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

| REVENUE RECOGNITION

| Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company's activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

| The company recognises revenue when:

| The amount of revenue can be reliably measured;

| it is probable that future economic benefits will flow to the entity;

| and specific criteria have been met for each of the company's activities.

| TAX

| The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

| The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

| DEFERRED TAX

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Imeds4u Ltd (Registered number: 09965369) |

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| TANGIBLE ASSETS

| Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

| The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

| DEPRECIATION

| Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

| Asset class |  | Depreciation method and rate |  |

| Plant and machinery |  | 25% straight line method |  |

| FixturesandFittings |  | 25% straight line method |  |

| ComputerEquipment |  | 25% straight line method |  |

| GOODWILL

| Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company's interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

| AMORTISATION

| Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

| Asset class |  | Amortisation method and rate |  |

| Goodwill |  | 10% straight line method |  |

| CASH AND CASH EQUIVALENTS

| Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

| TRADE DEBTORS

| Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

| Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

| Imeds4u Ltd (Registered number: 09965369) |

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

3. | ACCOUNTING POLICIES - continued

| STOCKS

| Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

| The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

| TRADE CREDITORS

| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

| Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

| LEASES

| Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

| Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

| Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

| SHARE CAPITAL

| Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

4. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 6 (2024 - 5 ) .

| Imeds4u Ltd (Registered number: 09965369) |

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

5. | INTANGIBLE FIXED ASSETS

| Goodwill

£ |

| COST

| At 1 February 2024

| and 31 January 2025 | 16,350 |  |

| AMORTISATION

| At 1 February 2024 | 9,810 |  |

| Charge for year | 1,635 |  |

| At 31 January 2025 | 11,445 |  |

| NET BOOK VALUE

| At 31 January 2025 | 4,905 |  |

| At 31 January 2024 | 6,540 |  |

6. | TANGIBLE FIXED ASSETS

| Fixtures |

| Plant and |  | and |  | IT |

| machinery |  | fittings |  | equipment |  | Totals

£ | £ | £ | £ |

| COST

| At 1 February 2024

| and 31 January 2025 | 53,938 |  | 303 |  | 2,250 |  | 56,491 |  |

| DEPRECIATION

| At 1 February 2024 | 40,675 |  | 229 |  | 2,181 |  | 43,085 |  |

| Charge for year | 13,263 |  | 74 |  | 69 |  | 13,406 |  |

| At 31 January 2025 | 53,938 |  | 303 |  | 2,250 |  | 56,491 |  |

| NET BOOK VALUE

| At 31 January 2025 | - |  | - |  | - |  | - |  |

| At 31 January 2024 | 13,263 |  | 74 |  | 69 |  | 13,406 |  |

7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade debtors | 48,175 |  | 22,820 |  |

| Other debtors | 5,673 |  | 9,736 |  |

53,848 |  | 32,556 |  |

| Imeds4u Ltd (Registered number: 09965369) |

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Bank loans and overdrafts | 6,336 |  | 5,392 |  |

| Hire purchase contracts | 4,818 |  | 3,600 |  |

| Trade creditors | 22,766 |  | 22,130 |  |

| Taxation and social security | 8,338 |  | 11,649 |  |

| Other creditors | 59,570 |  | 38,486 |  |

101,828 |  | 81,257 |  |

9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2025 | 2024 |

£ | £ |

| Bank loans | 9,565 |  | 12,657 |  |

| Hire purchase contracts | 1,662 |  | 6,540 |  |

11,227 |  | 19,197 |  |

10. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2025 | 2024 |

| value: | £ | £ |

| 100 | Ordinary share | 1 | 100 |  | 100 |  |